Ensign Peak Advisors Portfolio holdings
AUM
$58.4B
This Quarter Return
-2.99%
1 Year Return
+23.83%
3 Year Return
+106.64%
5 Year Return
+193.2%
10 Year Return
–
AUM
$52.3B
AUM Growth
+$52.3B
(-7.1%)
Cap. Flow
-$1.13B
Cap. Flow
% of AUM
-2.17%
Top 10 Holdings %
Top 10 Hldgs %
29.58%
Holding
1,741
New
31
Increased
392
Reduced
561
Closed
51
Top Buys
| 1 |
FTAI Aviation
FTAI
|
$141M |
| 2 |
Johnson & Johnson
JNJ
|
$117M |
| 3 |
Atlassian
TEAM
|
$76.6M |
| 4 |
UnitedHealth
UNH
|
$73.4M |
| 5 |
Capital One
COF
|
$71.8M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$302M |
| 2 |
Thermo Fisher Scientific
TMO
|
$143M |
| 3 |
Apple
AAPL
|
$126M |
| 4 |
Meta Platforms (Facebook)
META
|
$85M |
| 5 |
NVIDIA
NVDA
|
$80.5M |
Sector Composition
| 1 | Technology | 27.61% |
| 2 | Financials | 14.61% |
| 3 | Healthcare | 13.57% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Communication Services | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Avanos Medical
AVNS
$554M
| $342K | ﹤0.01% | 23,889 | – | – |
|
1627
Evolent Health
EVH
$1.12B
| $342K | ﹤0.01% | 36,089 | – | – |
|
1628
Viasat
VSAT
$4.34B
| $341K | ﹤0.01% | 32,766 | – | – |
|
1629
Novavax
NVAX
$1.21B
| $336K | ﹤0.01% | 52,400 | – | – |
|
1630
D-Wave Quantum
QBTS
$5.34B
| $329K | ﹤0.01% | +43,350 | New | +$329K |
|
1631
Fox Factory Holding Corp
FOXF
$1.21B
| $329K | ﹤0.01% | 14,113 | – | – |
|
1632
Applied Digital
APLD
$4.19B
| $329K | ﹤0.01% | +58,550 | New | +$329K |
|
|
GRAL
1633
GRAIL, Inc. Common Stock
GRAL
$1.18B
| $329K | ﹤0.01% | 12,877 | – | – |
|
1634
Vera Therapeutics
VERA
$1.38B
| $325K | ﹤0.01% | 13,550 | – | – |
|
1635
Ranpak Holdings
PACK
$445M
| $321K | ﹤0.01% | 59,194 | – | – |
|
1636
AMN Healthcare
AMN
$796M
| $321K | ﹤0.01% | 13,115 | – | – |
|
1637
Great Southern Bancorp
GSBC
$717M
| $319K | ﹤0.01% | 5,759 | – | – |
|
1638
B&G Foods
BGS
$361M
| $317K | ﹤0.01% | +46,100 | New | +$317K |
|
1639
Simulations Plus
SLP
$285M
| $315K | ﹤0.01% | 12,861 | – | – |
|
1640
Legend Biotech
LEGN
$6.41B
| $307K | ﹤0.01% | 9,050 +1,200 | +15% | +$40.7K |
|
1641
Scholastic
SCHL
$644M
| $306K | ﹤0.01% | 16,218 | – | – |
|
1642
MaxLinear
MXL
$1.37B
| $305K | ﹤0.01% | 28,112 | – | – |
|
1643
Cohu
COHU
$929M
| $300K | ﹤0.01% | 20,401 | – | – |
|
1644
Rigetti Computing
RGTI
$5.26B
| $298K | ﹤0.01% | +37,650 | New | +$298K |
|
1645
Monro
MNRO
$497M
| $295K | ﹤0.01% | 20,416 | – | – |
|
|
BOLD
1646
Boundless Bio
BOLD
$25.1M
| $283K | ﹤0.01% | 187,500 | – | – |
|
1647
Merus
MRUS
$4.98B
| $282K | ﹤0.01% | 6,700 -107,300 | -94% | -$4.52M |
|
1648
Myriad Genetics
MYGN
$593M
| $280K | ﹤0.01% | 31,606 | – | – |
|
1649
XP
XP
$9.56B
| $279K | ﹤0.01% | 20,300 +9,600 | +90% | +$132K |
|
1650
Intellia Therapeutics
NTLA
$1.22B
| $278K | ﹤0.01% | 39,169 | – | – |
|